bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2013: M A M F J
2012: D N O S A J J M

 
  Other news for:
Breast Neoplasms
Neoplasms
Estrogens
Genetics
Pregnancy Complications
 Resources from HONselect
Estrogen Level in Pregnancy May Affect Breast Cancer Risk in Daughters
Too much of the hormone can disable tumor suppressor gene, researchers report

By Robert Preidt

TUESDAY, April 9 (HealthDay News) -- Daughters born to women who had excess levels of estrogen during pregnancy may be at increased risk for breast cancer, a new study suggests.

That's because high estrogen levels in the womb can disable the powerful breast cancer tumor suppressor gene BRCA1 in daughters, the researchers at Georgetown Lombardi Comprehensive Cancer Center said in a Georgetown news release.

Their study of 1-year-old girls whose mothers had high estrogen levels during pregnancy also found that the daughters had other gene abnormalities that can contribute to the risk of breast cancer and breast cancer recurrence.

This includes a gene defect in the so-called unfolded protein response pathway, which has been linked to breast cancer risk and resistance to the breast cancer drug tamoxifen.

Although the study found an association between high estrogen levels in pregnancy and factors that raise breast cancer risk in daughters, it did not prove cause and effect.

If the findings are confirmed, they could be used to identify women at increased risk for breast cancer and to lower their risk before the disease develops, the researchers said.

There are drugs available that may make it "possible to reverse the increase in breast cancer risk and prevent development of resistance to tamoxifen in these women," study lead author Leena Hilakivi-Clarke, a professor of oncology at Georgetown Lombardi, said in the news release.

The study was to be presented Tuesday at the American Association for Cancer Research annual meeting, in Washington, D.C. The data and conclusions of research presented at meetings are typically considered preliminary until published in a peer-reviewed medical journal.

More information

Breastcancer.org has more about breast cancer risk.

SOURCE: Georgetown University Medical Center, news release, April 9, 2013

Health News Copyright © 2013 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=675116

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Neoplasms
Breast
Breast Neoplasms
Risk
Nuclear Family
Affect
Research Personnel
Women
Association
Tamoxifen
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact